P25451 (PSB3_YEAST) Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)

Proteasome subunit beta type-3 UniProtKBInterProSTRINGInteractive Modelling

205 aa; Sequence (Fasta) ; 9 identical sequences: Saccharomyces cerevisiae: G2WCY6, C8Z7B3, C7GRS8, A0A6L0YA22, A6ZR51, B3LRL3; Saccharomyces pastorianus: A0A6C1DRE5; Saccharomyces boulardii: A0A0L8VRR5; Saccharomyces cerevisiae x Saccharomyces kudriavzevii: H0GF76

Available Structures

312 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
20×MG;2-205
Assess
Ligand-induced aziridine-formation at subunit beta5 of the yeast 20S proteasome Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
11×MG;3K4;2-205
Assess
Crystal structure of epoxomicin:20s proteasome reveals a molecular basis for selectivity of alpha,b… Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;2-205
Assess
yCP beta5-M45T mutant in complex with bortezomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;BO2;2-205
Assess
Yeast 20S proteasome at 2.3 A resolution Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
Yeast 20S proteasome beta2-G45A mutant in complex with carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;GWZ;MES;SO4;2-205
Assess
Ligand-induced Lys33-Thr1 crosslinking at subunit beta5 of the yeast 20S proteasome Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
11×MG;ABA;2-205
Assess
A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
20×MG;2-205
Assess
Yeast 20S proteasome in complex with Ac-LAA-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome in complex with Ac-APLL-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Crystal structure of yeast 20S proteasome in complex with ligand 2a Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MES;2-205
Assess
Yeast 20S proteasome in complex with Ac-LAV-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome with human beta5i (1-138; R57T) Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28062; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;CL;2-205
Assess
yCP in complex with tripeptidic epoxyketone inhibitor 8 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;MES;38N;2-205
Assess
Crystal structure of the yeast 20S proteasome in complex with Salinosporamide derivatives: slow sub… Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
GPT;2-205
Assess
Yeast 20S proteasome in complex with Ac-LAF-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome beta2-H114D mutant in complex with Ac-PAE-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
Yeast 20S proteasome in complex with Ac-LAE-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bo… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28062; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;BO2;2-205
Assess
Yeast 20S proteasome beta5-T1A beta5-K81R double mutant in complex with Bortezomib, propeptide expr… Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
11×MG;CL;BO2;2-205
Assess
Crystal structure of yeast 20S proteasome in complex with enone carmaphycin analogue 6 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
EC6;2-205
Assess
Yeast 20S proteasome beta5-D166N mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
Crystal structure of the yeast 20S proteasome in complex with Salinosporamide derivatives: irrevers… Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
SA1;2-205
Assess
Crystal structure of the yeast 20S proteasome in complex with 2b Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MES;2-205
Assess
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
11×MG;3K4;2-205
Assess
yCP in complex with MG132 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;ALD;2-205
Assess
Yeast 20S proteasome beta5-D166N mutant in complex with Carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
Yeast 20S proteasome in complex with the alkaloid indolo-phakellin (4) Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;3WE;2-205
Assess
Crystal structure of 20S proteasome in complex with hydroxylated salinosporamide Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
HYE;2-205
Assess
Yeast 20S proteasome beta2-G45A mutant in complex with ONX 0914 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;GQK;MES;SO4;2-205
Assess
yCP beta5-M45A mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;CL;2-205
Assess
yCP in complex with BSc4999 (alpha-Keto Phenylamide) Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
11×MG;3E5;2-205
Assess
Yeast 20S proteasome in complex with the peptidic non-covalent binding inhibitor RTS-V5 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;CL;FGY;MES;SO4;2-205
Assess
Yeast 20S proteasome in complex with N3-APAL-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome beta5-G48C mutant in complex with alpha-chloroacetamide 5 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome in complex with Ac-LAI-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
yCP in complex with Z-Leu-Leu-Leu-B(OH)2 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CIX;2-205
Assess
Crystal structure of 20s proteasome with novel inhibitor K-7174 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
WPI;2-205
Assess
yCP beta5-A49T-mutant in complex with bortezomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;BO2;2-205
Assess
Structure of yeast 20S open-gate proteasome with Compound 16 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;L3T;MES;2-205
Assess
Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with PR… Heteromer
O09061; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28063; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;39V;MES;2-205
Assess
Yeast 20S proteasome in complex with 44b Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;CL;GWT;MES;2-205
Assess
Yeast 20S proteasome beta7-delta7_Cter mutant in complex with Ac-PAE-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with ep… Heteromer
O09061; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28063; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;6NV;MES;2-205
Assess
yCP beta5-A49V mutant in complex with carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
yCP beta5-C63F mutant in complex with the epoxyketone inhibitor ONX 0914 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;04C;MES;2-205
Assess
yCP beta5-C63F mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;CL;2-205
Assess
Yeast 20S proteasome in complex with N3-APnLL-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
yCP in complex with Z-Leu-Leu-Leu-ketoaldehyde Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;2MK;2-205
Assess
Yeast 20S proteasome with human beta5i (1-138; V31M) and human beta6 (97-111; 118-133) in complex w… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28062; P30656; P30657; P32379; P38624; P40302; P40303;
11×MG;CL;04C;2-205
Assess
Yeast 20S proteasome in complex with 13 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;GQT;2-205
Assess
Yeast 20S proteasome beta5-T1S mutant in complex with Bortezomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;BO2;2-205
Assess
yCP beta5-A49S-mutant in complex with carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with PR… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28062; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;39V;MES;2-205
Assess
Yeast 20S proteasome with human beta2c (S171G) in complex with 13 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P30656; P30657; P32379; P38624; P40302; P40303; Q99436;
MG;GQT;2-205
Assess
Yeast 20S proteasome beta7-delta7_Cter mutant in complex with Ac-PAY-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
yCP beta5-A50V mutant in complex with carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
Structure of yeast 20S open-gate proteasome with Compound 24 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;OEU;MES;2-205
Assess
Yeast 20S proteasome in complex with Ac-PAA-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome in complex with H-APLL-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome in complex with Ac-PLL-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome beta2-H114D mutant in complex with Ac-PAD-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
Structure of yeast 20S open-gate proteasome with Compound 6 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;LZT;MES;2-205
Assess
Yeast 20S proteasome in Complex with Kendomycin Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
2YD;2-205
Assess
Yeast 20S proteasome in complex with a beta1 / beta2 specific non-peptidic sulfonamide Ligand Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;4UC;2-205
Assess
Yeast 20S proteasome beta5-D166N mutant in complex with MG132 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
11×MG;CL;ALD;2-205
Assess
Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with ON… Heteromer
O09061; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28063; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;04C;MES;2-205
Assess
Yeast 20S proteasome beta2-T(-2)V mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;2-205
Assess
Yeast 20S proteasome with human beta5i (1-138; V31M) and human beta6 (97-111; 118-133) in complex w… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28062; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;39V;2-205
Assess
yCP beta5-A50V mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;CL;2-205
Assess
Yeast 20S proteasome beta5-H(-2)T-T1A double mutant in complex with Carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
Proteasome Inhibition by Fellutamide B Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
FEB;2-205
Assess
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with ep… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28062; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;79P;MES;2-205
Assess
yCP beta5-M45I mutant in complex with bortezomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;BO2;2-205
Assess
Yeast 20S proteasome beta5-H(-2)A-T1A-K81R triple mutant in complex with Carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
Structure of yeast 20S open-gate proteasome with Compound 20 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
20×MG;3SD;MES;2-205
Assess
Structure of yeast 20S proteasome with bortezomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
BO2;2-205
Assess
Yeast 20S proteasome in complex with Cystargolide B Derivative 1 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;EQE;2-205
Assess
yeast 20S proteasome:glidobactin A-complex Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
GDT;2-205
Assess
Yeast 20S proteasome with human beta2i (1-53) Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303; P40306;
MG;CL;SO4;2-205
Assess
Yeast 20S proteasome beta7-delta7_Cter mutant in complex with Ac-PAF-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome beta5-K33A mutant (propeptide expressed in trans) Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
Yeast 20S Proteasome in complex with Vibralactone Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
1Y9;2-205
Assess
Yeast 20S proteasome in complex with Cystargolide B Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;EPW;2-205
Assess
Crystal structure of yeast CP in complex with Belactosin C Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
BFO;2-205
Assess
yCP beta5-M45T mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
yCP beta5-M45I mutant in complex with the epoxyketone inhibitor ONX 0914 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;04C;MES;2-205
Assess
Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with ep… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28074; P30656; P30657; P32379; P38624; P40302; P40303;
11×MG;CL;04C;MES;2-205
Assess
Yeast 20S proteasome with human beta5i (1-138; R57T)in complex with PR-924 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28062; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;39V;MES;2-205
Assess
Crystal structure of the yeast 20S proteasome in complex with ligand 2c Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
2-205
Assess
Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with ca… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28074; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;CL;3BV;MES;2-205
Assess
Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bo… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28074; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;CL;BO2;2-205
Assess
Yeast 20S proteasome in complex with PR-VI modulator Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MPD; 38×GOL; 56×MG;2-205
Assess
Yeast 20S proteasome in complex with Ac-PAL-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome beta5-L(-49S)_D17N double mutant in complex with Carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
Yeast 20S proteasome beta2-H116D mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with th… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28062; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;7DX;2-205
Assess
Yeast 20S proteasome with human beta5i (1-138; V31M) and human beta6 (97-111; 118-133) in complex w… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28062; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;6NV;2-205
Assess
Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with ep… Heteromer
O09061; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28063; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;79P;MES;2-205
Assess
Yeast 20S proteasome beta2-H114D mutant in complex with Ac-LAD-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;MES;CL;K;2-205
Assess
Yeast 20S proteasome beta2-T1A mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
Yeast 20S proteasome beta2-H114D mutant in complex with Ac-LAE-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome with human beta2i (1-53) in complex with 39 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303; P40306;
MG;CL;GT8;MES;2-205
Assess
yCP beta5-M45I mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
yCP in complex with Z-Leu-Leu-Leu-ketoamide Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;2LV;2-205
Assess
Yeast 20S proteasome in complex with PR-957 (epoxide) Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
049;2-205
Assess
Yeast 20S proteasome in complex with the vinyl sulfone LU102 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
1G1;2-205
Assess
Yeast 20S proteasome beta5-T1A mutant in complex with Syringolin A, propeptide expressed in trans Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;SRG;2-205
Assess
Yeast 20S proteasome in complex with 20 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;GT5;2-205
Assess
Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with PR… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28074; P30656; P30657; P32379; P38624; P40302; P40303;
11×MG;CL;MES;39V;2-205
Assess
Yeast 20S proteasome beta2-H116N mutant in complex with Ac-PAE-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
Structure of yeast 20S open-gate proteasome with Compound 34 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;P3N;MES;2-205
Assess
Yeast 20S proteasome with human beta2c (S171G) Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P30656; P30657; P32379; P38624; P40302; P40303; Q99436;
MG;CL;2-205
Assess
Yeast 20S proteasome with human beta2i (1-53) in complex with 16 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303; P40306;
MG;CL;GRW;2-205
Assess
Yeast 20S proteasome in complex with epoxyketone inhibitor 14 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;CL;6N5;MES;2-205
Assess
Alpha-keto-aldehyde binding mechanism reveals a novel lead structure motif for proteasome inhibition Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
EP9;2-205
Assess
Crystal structure of the yeast 20S proteasome in complex with syringolin B Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
SY2;2-205
Assess
Yeast 20S proteasome beta2-H116D mutant in complex with Ac-LAE-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;MES;2-205
Assess
yCP beta5-M45T mutant in complex with carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
Yeast 20S proteasome in complex with 29 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;GTW;2-205
Assess
Yeast 20S proteasome in complex with Ac-LAL-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome in complex with N3-A(4,4-F2P)nLL-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;MES;CL;2-205
Assess
Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with ep… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28074; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;CL;MES;6NV;2-205
Assess
Yeast 20S proteasome in complex with Ac-LLL-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome beta5-K33A mutant (propeptide expressed in trans) in complex with Carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
Yeast 20S proteasome beta2-H116N mutant in complex with Ac-LAE-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome in complex with 5 (7- and 6-membered ring) Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;GVZ;GW2;MES;2-205
Assess
Yeast 20S proteasome beta2-H116D mutant in complex with Ac-PAE-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;2-205
Assess
Structure of yeast 20S open-gate proteasome with Compound 8 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;L2T;MES;2-205
Assess
Yeast 20S proteasome beta7-delta7_Cter mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
Crystal structure of yeast 20S proteasome in complex with the natural product carmaphycin A Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
OV1;2-205
Assess
Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28074; P30656; P30657; P32379; P38624; P40302; P40303;
CL; 12×MG;2-205
Assess
Yeast 20S proteasome in complex with 7 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;GQQ;2-205
Assess
yCP beta5-M45A mutant in complex with the epoxyketone inhibitor ONX 0914 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;04C;MES;2-205
Assess
yCP in complex with carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
Crystal structure of yeast 20S proteasome in complex with spirolactacystin Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
SLA;2-205
Assess
Yeast 20S proteasome beta2-H116E mutant in complex with Ac-LAE-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome in complex with 41b Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;CL;GWK;MES;2-205
Assess
Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with ep… Heteromer
O09061; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28063; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;6N5;MES;2-205
Assess
yCP beta5-A50V mutant in complex with the epoxyketone inhibitor ONX 0914 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;04C;MES;2-205
Assess
Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bo… Heteromer
O09061; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28063; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;BO2;2-205
Assess
Yeast 20S proteasome beta2-G45A mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;SO4;2-205
Assess
Crystal structure of yeast 20S proteasome in complex with epoxyketone carmaphycin analogue 3 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
OV2;2-205
Assess
Yeast 20S proteasome with human beta2c (S171G) in complex with ONX 0914 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P30656; P30657; P32379; P38624; P40302; P40303; Q99436;
10×MG;CL;GQK;MES;SO4;2-205
Assess
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28062; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
Yeast 20S proteasome beta2-H116E mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;MES;2-205
Assess
Yeast 20S proteasome in complex with Ac-PAE-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;2-205
Assess
Proteasome in complex with hydroxyurea derivative HU10 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MES;H10;2-205
Assess
Yeast 20S proteasome in complex with Macyranone A Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;7IM;MES;2-205
Assess
Yeast 20S proteasome in complex with 4 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;GQH;2-205
Assess
Yeast 20S proteasome beta2-H116E mutant in complex with Ac-PAE-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
Yeast 20S proteasome beta2-G45A mutant in complex with bortezomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;BO2;2-205
Assess
yCP beta5-A49V mutant in complex with bortezomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;BO2;2-205
Assess
yCP beta5-A49V mutant in complex with the epoxyketone inhibitor ONX 0914 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;04C;MES;2-205
Assess
Yeast 20S proteasome beta5-H(-2)L-T1A double mutant in complex with Carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with ep… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28062; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;6NV;MES;2-205
Assess
Yeast 20S proteasome beta2-G170A mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
yCP in complex with bortezomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;BO2;2-205
Assess
yCP beta5-A49V mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;CL;2-205
Assess
yCP beta5-C52F mutant in complex with Omuralide Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;SLA;2-205
Assess
Yeast 20S proteasome in complex with the belactosin derivative 3e Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
1KR;2-205
Assess
Yeast 20S proteasome in complex with Ac-PAF-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Crystal structure of Salinosporamide A in complex with the yeast 20S proteasome Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
SA1;2-205
Assess
Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with ep… Heteromer
O09061; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28063; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;79L;MES;2-205
Assess
Yeast 20S proteasome in complex with Ac-LAD-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;MES;CL;2-205
Assess
Yeast 20S proteasome beta7-delta7_Cter mutant in complex with Ac-PAL-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with ep… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28062; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;79L;MES;2-205
Assess
yCP in complex with tripeptidic epoxyketone inhibitor 2 (PR924) Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;MES;39V;2-205
Assess
Yeast 20S proteasome in complex with alkyne-PI Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;5BZ;2-205
Assess
Yeast 20S proteasome beta5-G48C mutant in complex with ONX 0914 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;04C;NA;2-205
Assess
yCP in complex with tripeptidic epoxyketone inhibitor 9 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;MES;38X;2-205
Assess
Yeast 20S proteasome in complex with Ac-LAY-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with ep… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28074; P30656; P30657; P32379; P38624; P40302; P40303;
12×MG;CL;MES;79P;2-205
Assess
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with ON… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28062; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;04C;MES;2-205
Assess
20S yeast proteasome in complex with cepafungin I Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
2-205
Assess
Yeast 20S proteasome in complex with octreotide-PI Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;5BY;2-205
Assess
Yeast 20S proteasome beta2-G170A mutant in complex with Bortezomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;BO2;2-205
Assess
yeast 20S proteasome in complex with the Syringolin-Glidobactin chimera Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
2-205
Assess
Yeast 20S proteasome with human beta2c (S171G) in complex with 29 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P30656; P30657; P32379; P38624; P40302; P40303; Q99436;
MG;CL;GTW;SO4;2-205
Assess
Yeast 20S proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28074; P30656; P30657; P32379; P38624; P40302; P40303;
11×MG;CL;MES;6N5;2-205
Assess
Yeast 20S proteasome in complex with Ac-PAY-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
Yeast 20S proteasome beta1-T1A mutant in complex with Carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
Crystal structure of the yeast 20S proteasome in complex with bortezomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
BO2;2-205
Assess
yCP beta5-A49T-mutant in complex with ONX 0914 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;04C;MES;2-205
Assess
Yeast 20S proteasome in complex with epoxyketone inhibitor 16 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;79P;MES;2-205
Assess
Yeast 20S proteasome in complex with 43 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;CL;MES;GVW;2-205
Assess
Yeast 20S proteasome in complex with 39 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;CL;GT8;MES;2-205
Assess
Yeast 20S proteasome beta5-L(-49)S-K33A mutant in complex with Carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
yCP beta5-M45A mutant in complex with bortezomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;BO2;2-205
Assess
yCP beta5-A49T-A50V-double mutant in complex with carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
Crystal structure of yeast 20S proteasome in complex with vinylketone carmaphycin analogue VNK1 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
ONK;VNK;2-205
Assess
Yeast 20S proteasome in complex with the dimerized linear mimetic of TMC-95A - yCP:4e Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MES;2-205
Assess
Yeast 20S proteasome beta5-G48C mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
Yeast 20S proteasome beta5-T1S mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;MES;2-205
Assess
yCP beta5-A49S-mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
Yeast 20S proteasome beta5-K33A mutant (propeptide expressed in trans) in complex with MG132 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;ALD;2-205
Assess
yCP in complex with tripeptidic epoxyketone inhibitor 11 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;MES;37Y;2-205
Assess
Yeast 20S proteasome in complex with glidobactin-like natural product HB334 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;QOB;2-205
Assess
TMC-95 based biphenyl-ether macrocycles: specific proteasome inhibitors Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
BIQ;2-205
Assess
Crystal structure of yeast 20S proteasome in complex with the epimer form of spirolactacystin Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
SLR;2-205
Assess
Structure of yeast 20S open-gate proteasome with Compound 25 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;3OE;MES;2-205
Assess
Yeast 20S proteasome with human beta2c (S171G) in complex with 16 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P30656; P30657; P32379; P38624; P40302; P40303; Q99436;
MG;CL;GRW;SO4;2-205
Assess
Yeast 20S proteasome with human beta5i (1-138;V31M) and human beta6 (97-111; 118-133) Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28062; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
Yeast 20S proteasome beta5-T1S mutant in complex with Carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
yCP beta5-A49T-A50V-double mutant in complex with bortezomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;BO2;2-205
Assess
yCP beta5-A49T-mutant in complex with carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
Yeast 20S proteasome in complex with 16 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;GRW;2-205
Assess
Yeast 20S proteasome with human beta2i (1-53) in complex with 20 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303; P40306;
MG;CL;GT5;2-205
Assess
yCP in complex with Z-Leu-Leu-Leu-epoxyketone Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;2L0;2LR;2-205
Assess
Yeast 20S proteasome beta5-D17N mutant in complex with Carfilzomib; Propeptide expressed in trans Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
Yeast 20S proteasome beta5-G48C mutant in complex with alpha-chloroacetamide 1 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;2-205
Assess
yeast 20S proteasome:syringolin A-complex Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
SRG;2-205
Assess
Ligand-induced Lys33-Thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
11×MG;2-205
Assess
yCP in complex with the epoxyketone inhibitor ONX 0914 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;04C;MES;NA;2-205
Assess
Yeast 20S proteasome in complex with Ac-PAD-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
Yeast 20S proteasome in complex with the peptidic epoxyketone inhibitor 27 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;6KF;MES;2-205
Assess
Yeast 20S proteasome in complex with 18 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;GRT;2-205
Assess
Yeast 20S proteasome beta2-H116D mutant in complex with Ac-PAD-ep Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
yCP beta5-C63F mutant in complex with bortezomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;BO2;2-205
Assess
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with ca… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28062; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
yCP beta5-C52F mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
yCP beta5-M45V mutant in complex with carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
yCP beta5-A49T-A50V double mutant in complex with the epoxyketone inhibitor ONX 0914 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;04C;MES;2-205
Assess
Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with ON… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28074; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;04C;MES;2-205
Assess
Yeast 20S proteasome in complex with epoxyketone inhibitor 18 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
11×MG;CL;MES;6NV;2-205
Assess
Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with ca… Heteromer
O09061; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28063; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
yCP in complex with tripeptidic epoxyketone inhibitor 17 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;MES;39Q;2-205
Assess
yCP in complex with Omuralide Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;SLA;2-205
Assess
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with ep… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28062; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;38X;MES;2-205
Assess
Yeast 20S proteasome in complex with the vinyl sulfone LU122 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
1G5;2-205
Assess
Yeast 20S proteasome beta1-T1A beta2-T1A double mutant in complex with Carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
yCP beta5-C52F mutant in complex with carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
Yeast 20S proteasome with human beta5i (1-138; V31M) and human beta6 (97-111; 118-133) in complex w… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28062; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;MES;79P;2-205
Assess
yCP beta5-M45V mutant in complex with bortezomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;BO2;2-205
Assess
Yeast 20S proteasome in complex with the dimerized linear mimetic of TMC-95A - yCP:3a Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MES;2-205
Assess
Yeast 20S proteasome with human beta2i (1-53) in complex with 29 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303; P40306;
MG;CL;GTW;2-205
Assess
Yeast 20S proteasome beta5-T1C mutant in complex with Carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
yCP beta5-A50V mutant in complex with bortezomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;BO2;2-205
Assess
Yeast 20S proteasome beta2-H116N mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
CL;MG;2-205
Assess
Yeast 20S proteasome beta2-H114D mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
Yeast 20S proteasome with human beta2i (1-53) in complex with 13 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303; P40306;
MG;CL;GQT;2-205
Assess
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with ep… Heteromer
P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P28062; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;6N5;MES;2-205
Assess
Yeast 20S Proteasome in complex with Homosalinosporamide A Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;F6K;2-205
Assess
Yeast 20S proteasome in complex with glidobactin-like natural product HB333 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;QOH;2-205
Assess
yCP beta5-M45V mutant in complex with the epoxyketone inhibitor ONX 0914 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;04C;MES;2-205
Assess
Crystal Structure of the Yeast 20S Proteasome in Complex with Homobelactosin C Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
ESY;2-205
Assess
Yeast 20S proteasome with human beta2c (S171G) in complex with 4 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P30656; P30657; P32379; P38624; P40302; P40303; Q99436;
MG;CL;GQH;SO4;2-205
Assess
Yeast 20S proteasome in complex with Cystargolide B Derivative 2 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;EQB;2-205
Assess
Yeast 20S proteasome with human beta2c (S171G) in complex with 7 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P30656; P30657; P32379; P38624; P40302; P40303; Q99436;
MG;CL;GQQ;SO4;2-205
Assess
yCP in complex with Z-Leu-Leu-Leu-vinylsulfone Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;2M1;2-205
Assess
20S yeast proteasome in complex with glidobactin Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
2-205
Assess
yCP beta5-A49S mutant in complex with the epoxyketone inhibitor ONX 0914 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;04C;MES;2-205
Assess
Yeast 20S proteasome with human beta2i (1-53) in complex with ONX 0914 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303; P40306;
MG;CL;GQK;MES;SO4;2-205
Assess
Yeast 20S proteasome with human beta2c (S171G) in complex with 18 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P30656; P30657; P32379; P38624; P40302; P40303; Q99436;
MG;CL;GRT;SO4;2-205
Assess
yCP in complex with BOC-ALA-ALA-ALA-CHO Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
11×MG;2-205
Assess
yCP beta5-A49T-mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;2-205
Assess
Yeast 20S proteasome with human beta2i (1-53) in complex with 4 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303; P40306;
MG;CL;GQH;2-205
Assess
yCP beta5-M45A mutant in complex with carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
yCP beta5-M45V mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
Yeast 20S proteasome with human beta2i (1-53) in complex with 43 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303; P40306;
MG;CL;GVW;MES;2-205
Assess
yCP beta5-C52F mutant in complex with the epoxyketone inhibitor ONX 0914 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;04C;MES;2-205
Assess
yCP beta5-A49S-mutant in complex with bortezomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;BO2;2-205
Assess
yCP beta5-C63F mutant in complex with carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
CL;3BV;MES;MG;2-205
Assess
yCP beta5-C52F mutant in complex with bortezomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;BO2;2-205
Assess
yCP beta5-M45I mutant in complex with carfilzomib Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;3BV;MES;2-205
Assess
yCP beta5-M45T mutant in complex with the epoxyketone inhibitor ONX 0914 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
CL;04C;MES;MG;2-205
Assess
Yeast 20S proteasome in complex with belactosin C derivative 3 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;4KF;2-205
Assess
Yeast 20S proteasome in complex with the peptidic epoxyketone inhibitor 15 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;6KG;MES;2-205
Assess
Crystal Structure of the yeast 20S Proteasome:TMC-95A complex: A non-covalent Proteasome Inhibitor Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;2-205
Assess
Yeast 20S proteasome with human beta2c (S171G) in complex with 20 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P30656; P30657; P32379; P38624; P40302; P40303; Q99436;
MG;CL;GT5;SO4;2-205
Assess
Yeast 20S proteasome in complex with Blm-pep activator Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
12×CL;MG; 16×EDO;GOL;2-205
Assess
Yeast 20S proteasome in complex with glidobactin-like natural product HB335 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;QOE;2-205
Assess
Proteasome Activator Complex Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303; P43583;
2-205
Assess
yCP beta5-A49T-A50V-double mutant Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MG;CL;2-205
Assess
Yeast 20S proteasome in complex with the dimerized linear mimetic of TMC-95A - yCP:4a Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
MES;0L1;2-205
Assess
Yeast 20S proteasome with human beta2c (S171G) in complex with 39 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P30656; P30657; P32379; P38624; P40302; P40303; Q99436;
MG;CL;GT8;MES;SO4;2-205
Assess
Yeast 20S proteasome with human beta2i (1-53) in complex with 18 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303; P40306;
MG;CL;GRT;2-205
Assess
Yeast 20S proteasome in complex with the vinyl sulfone LU112 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
1G6;2-205
Assess
Structure of yeast 20S proteasome with Compound 1 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
10×MG;LXT;MES;2-205
Assess
Yeast 20S proteasome with a mutation of alpha7 subunit Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
2-205
Assess
CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FR… Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303; Q9U8G2;
14×MG;2-205
Assess
Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator PA26 fr… Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303; Q9U8G2;
2-205
Assess
Yeast 20S proteasome in complex with PR-957 (morpholine) Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
04C;2-205
Assess
Yeast 20S proteasome with human beta2i (1-53) in complex with 7 Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303; P40306;
MG;CL;GQQ;2-205
Assess
Structure of yeast 26S proteasome in M1 state derived from Titan dataset Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
2-205
Assess
Yeast proteasome in translocation competent state (C3-a) Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
2-205
Assess
26S proteasome, s1 state Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
ATP;MG;ADP;2-205
Assess
26S proteasome in presence of ATP (s1) Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P33297; P33298; P33299; P38624; P40302; P40303; P40327; P53549; Q01939;
ATP;MG;ADP;2-205
Assess
26S proteasome, s5 state Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
ATP;MG;ADP;2-205
Assess
26S proteasome, s3 state Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
ADP;MG;ATP;2-205
Assess
26S proteasome, s4 state Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
ATP;MG;ADP;2-205
Assess
The resting state of yeast proteasome Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
2-205
Assess
Yeast proteasome in Ub-accepted state (C1-b) Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
2-205
Assess
yeast proteasome in Ub-engaged state (C2) Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
2-205
Assess
Yeast proteasome in resting state (C1-a) Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
2-205
Assess
26S proteasome in presence of AMP-PNP (s3) Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
ANP;MG;ADP;2-205
Assess
Yeast 26S proteasome bound to ubiquitinated substrate (4D motor state) Heteromer
P07818; P0CH08; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P33297; P33298; P33299; P38624; P40302; P40303; P40327; P43588; P53549; Q01939;
ATP;ADP;2-205
Assess
Structure of yeast 26S proteasome in M2 state derived from Titan dataset Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
2-205
Assess
26S proteasome, s2 state Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
ATP;MG;ADP;2-205
Assess
26S proteasome in presence of BeFx (s4) Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P43593; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
ATP;MG;ADP;2-205
Assess
26S proteasome in presence of ATP (s2) Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P33297; P33298; P33299; P38624; P40302; P40303; P40327; P53549; Q01939;
MG;ATP;ADP;2-205
Assess
yeast proteasome in substrate-processing state (C3-b) Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
2-205
Assess
Yeast proteasome-ADP-AlFx Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
2-205
Assess
26S proteasome, s6 state Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
ATP;MG;ADP;2-205
Assess
Cryo-EM structure of the Pre3-1 20S proteasome core particle Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P38624; P40302; P40303;
2-205
Assess
Deep classification of a large cryo-EM dataset defines the conformational landscape of the 26S prot… Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
2-205
Assess
Deep classification of a large cryo-EM dataset defines the conformational landscape of the 26S prot… Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
2-205
Assess
Deep classification of a large cryo-EM dataset defines the conformational landscape of the 26S prot… Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
2-205
Assess
Structure of the 26S proteasome-Ubp6 complex Heteromer
O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P43593; P53549; P62987; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377;
2-205
Assess
Structure of Proteasome-Pba1-Pba2 Complex Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P30657; P32379; P36040; P38624; P40302; P40303; Q05778;
16×MG;LDZ;3-205
Assess
Cryo-EM structure of 13S proteasome core particle assembly intermediate purified from Pre3-1 protea… Heteromer
P21242; P21243; P22141; P23638; P23639; P25043; P32379; P36040; P38293; P40302; P40303; Q05778;
5-200
Assess
Cryo-EM structure of Pre-15S proteasome core particle assembly intermediate purified from Pre3-1 pr… Heteromer
P21242; P21243; P22141; P23638; P23639; P23724; P25043; P30656; P32379; P36040; P38293; P40302; P40303; Q05778;
8-200
Assess

Alignments